Welcome to MyStrategist

Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today

Subscribe Browse

Latest from Market Pathways

Global Medical Device Regulatory, Reimbursement, and Policy Review

Start a free trial and unlock 5-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways

Start Trial

Latest from MedTech Strategist

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Investors & Dealmaking

Supermoon Capital: Investing in Sleep

Sleep health is a highly nuanced and highly fragmented field, and though there are dozens of disorders in the category, insomnia and sleep apnea have traditionally been its defining indications. Supermoon Capital, a VC firm entirely dedicated to sleep, is pushing boundaries in both clinical and consumer spaces to elucidate and improve the universal activity that humans do for a third of their lives.

Don't Just Advertise... Strategize!

Advertise with MedTech Strategist and be seen by medtech's most influential executives.

Learn More

Latest from Community Blog

MedTech Strategist's free Community Blog explores the passion behind the people, technologies, and companies impacting the global device space.

Regulatory & Reimbursement

Pathways' Pick of the Week: MDR Extension Proposed

The European Commission makes good on its promise to give legacy devices a few more years to transition to the MDR. Excerpted from Pathways' Picks January 11: Pathways’ Picks January 11: Codifying CED, Moving MDR Dates, and More from US, Europe, and Asia.

Our strategic publications provide actionable intelligence to support each member of your organization. Check to see if your company has access.

Learn More